A MOMENT FOR YOU
What’s one small step you can take today?
No perfect answers. Just a little room to reflect.
By Daniel J. Callahan, DSW, LMSW, ICRC-ADC
A weekly shot can quiet the hunger, but it can’t tell you why you reach for food at 10 o’clock at night. That gap, between what a medication does and what a person still has to learn, is exactly what the federal government is now putting into writing for millions of people.
Starting with the 2027 plan year, federal employee health plans will require people who take GLP-1 drugs and other anti-obesity medications for weight loss to take part in intensive behavioral therapy, both before they start and while they stay on the medication. Becker’s Payer Issues reported the change on November 17, and I went to the Office of Personnel Management’s own documents to see exactly what it says.
I think this is worth talking about even if you have never held a federal job. It gets at a question I care about a lot: what does lasting change actually take?
What OPM actually said
OPM runs the Federal Employees Health Benefits (FEHB) Program, which now includes the Postal Service Health Benefits (PSHB) Program. According to OPM’s Open Season highlights for the 2027 plan year, the combined program covers “approximately 7.9 million Federal employees, U.S. Postal Service employees, certain Tribal employees, annuitants, and their eligible family members.” Here is the key passage, word for word:
“Plans will continue to cover at least one GLP-1 anti-obesity medication and at least two oral anti-obesity medications. For 2027, all FEHB and PSHB Carriers will require documented participation in an evidence-based intensive behavioral therapy (IBT) program both prior to and during treatment with anti-obesity medications.”
The same document says plans “are expected to cover specified individual and group intensive behavioral therapy and medical nutrition therapy services, including between 12–22 intensive behavioral therapy sessions per year depending on progress.”
The details for insurers are in OPM’s 2027 Call Letter to carriers (Carrier Letter 2026-07, dated March 31, 2026). A few lines stood out to me:
- OPM says carrier rules must make sure the member “has demonstrated and will continue participation in lifestyle interventions meeting the rigor of IBT” before starting treatment and while on the medication.
- It states plainly that “AOM must only be covered when used concurrently with IBT as described above.” (AOM stands for anti-obesity medication.)
- A signed statement won’t do it on its own. “Attestation statements alone from members or providers of prior weight loss attempts should not bypass these requirements.”
- An app alone doesn’t count, either. “Smartphone Applications or Artificial Intelligence (AI) only vendors are not eligible for coverage under this process; virtual programs must include options for a combination of human coaching and interaction along with AI prompts.”
- Getting pointed to a wellness website isn’t therapy. “Case management programs where members are solely referred to wellness resources related to weight management are not considered IBT.”
Open Season for 2027 coverage runs November 9 through December 14, 2026.
So what is intensive behavioral therapy?
The phrase sounds clinical, maybe even a little scary. It isn’t. OPM describes IBT as “a combination of structured lifestyle interventions pertaining to nutrition, physical activity, and behavior change.” In plain words, it’s regular, structured coaching on how you eat, how you move, and how you build habits that hold up on a bad day.
The Call Letter lists who can provide it, including physicians, nurse practitioners, physician assistants, people described as “exercise physiologists/lifestyle coaches or similarly qualified” (for IBT), registered dietitians, and “licensed mental health professionals who have training in obesity management.” Sessions can be in person or virtual.
One honest clarification. OPM says IBT sits “outside the realm of mental or behavioral health treatment for eating disorders.” So if you struggle with binge eating or another eating disorder, an IBT program is not a substitute for that care. Bring it up with your doctor and ask about a specialist.
Why the behavior piece matters
Some people will read this rule as one more hoop to jump through. I understand that. Prior authorization is frustrating, and nobody likes proving themselves to an insurance company.
But look at what the research says about what happens when treatment stops. In the STEP 1 trial extension, published in Diabetes, Obesity and Metabolism in 2022, researchers followed adults without diabetes for a year after they stopped weekly semaglutide (the drug in Wegovy) along with the lifestyle program that came with it. Over the 68 weeks of treatment, those on semaglutide lost an average of 17.3% of their body weight. Then the authors reported this:
“One year after withdrawal of once-weekly subcutaneous semaglutide 2.4 mg and lifestyle intervention, participants regained two-thirds of their prior weight loss, with similar changes in cardiometabolic variables.”
Their conclusion: “Findings confirm the chronicity of obesity and suggest ongoing treatment is required to maintain improvements in weight and health.”
I want to be careful here. That study stopped the medication and the lifestyle support at the same time, so it can’t tell us that coaching alone would have held the weight off. What it does show is that this is a long-term condition, not a one-time fix. Whether someone stays on a medication for years or eventually comes off it, the habits, routines, and coping skills built along the way are the part they keep.
The recovery parallel
This is where my world and the weight-loss world meet. In addiction treatment, the field has learned that medication can open a door, but counseling, support, and new routines are what help a person walk through it and stay on the other side. The pill or the shot changes the chemistry. It doesn’t change the reasons someone reached for the substance in the first place.
Food works on a lot of us the same way. We eat when we’re lonely, bored, stressed, tired, or celebrating. A GLP-1 can turn down the volume on cravings. That quiet can be a real gift. It may also be the first time in years a person can actually hear what’s underneath the urge. That’s the moment when good coaching or therapy can do its best work.
None of this is about shame. Weight is not a character flaw, and taking a medication your doctor prescribes is not cheating. Using every tool available is just smart.
What this means if you’re on a GLP-1
If you have FEHB or PSHB coverage, or you love someone who does, here are a few practical steps. They are general information, not medical advice.
- Read your 2027 plan brochure and look for how your plan will handle prior authorization and IBT for anti-obesity medications.
- Call your plan if you already take a GLP-1. OPM’s rule is written for anti-obesity medications used for weight loss. If you take one for type 2 diabetes or another condition, ask how the new rules apply to you.
- Talk with your doctor before you change or stop any medication, and ask what kind of behavioral program fits you.
- Treat the sessions as part of the treatment, not paperwork. You may get more out of them than you expect.
A few questions worth sitting with
Whether or not this rule touches you, these are worth a quiet minute:
- What does food do for you on a hard day?
- If the cravings got quieter tomorrow, what feelings might get louder?
- Which habit would you most want to still have five years from now?
- Who in your life would you let help you build it?
The long walk
That’s me in the photo, standing on a golf tee high above the ocean. It’s one of my favorite pictures because the course just keeps going along the cliffs, one hole after another. Lasting change looks a lot more like that walk than like a sprint. You don’t finish it in a day, and you’re better off with good company.
If any of those questions stirred something up, about food, stress, or the way you cope, it might be worth looking around Happy Recovery to see whether anything here speaks to you. No pressure. Sometimes just naming the pattern is the first step.
Sources: U.S. Office of Personnel Management. “Federal Benefits Open Season Highlights 2027 Plan Year.” https://www.opm.gov/healthcare-insurance/open-season/agency-benefits-officers/housing-for-os-materials/2026-federal-benefits-open-season-highlights-for-plan-year-2027.pdf. U.S. Office of Personnel Management. “Federal Employees Health Benefits and Postal Service Health Benefits Programs Call Letter,” FEHB Program Carrier Letter 2026-07, March 31, 2026. https://www.opm.gov/healthcare-insurance/carriers/fehb/2026/2026-07.pdf. Casolo, E. “Federal employee health plans to require behavioral therapy for weight loss drugs.” Becker’s Payer Issues, November 17, 2026. https://www.beckerspayer.com/payer/employer-sponsored/federal-employee-health-plans-to-require-behavioral-therapy-for-glp-1-weight-loss-drugs/. Wilding, J. P. H., et al. “Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.” Diabetes, Obesity and Metabolism, 2022;24(8):1553-1564. https://pubmed.ncbi.nlm.nih.gov/35441470/.
This post is for education, not medical, insurance, or legal advice. Coverage rules vary by plan, so check your plan brochure and talk with your plan and your doctor before making any changes to your treatment. Happy Recovery is not affiliated with OPM, any FEHB or PSHB carrier, or any drug manufacturer, and Wegovy is a trademark of its owner. If you are struggling with eating, mood, alcohol, or drugs, please talk with a qualified professional. The free, confidential SAMHSA National Helpline is 1-800-662-4357, and you can search for treatment at FindTreatment.gov. If you are in crisis, call or text 988.
—
AI transparency: I used AI to condense this from my notes and draft and reviewed it before posting. Facts and quotes belong to the original sources (the U.S. Office of Personnel Management, 2026; Becker’s Payer Issues, 2026; and Wilding et al., Diabetes, Obesity and Metabolism, 2022).
Keep the conversation going.
Sometimes hearing another person’s experience helps an idea settle in. Explore conversations about recovery, community, and finding a way forward.





